Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

Drug Resistance Updates

Volumn 11, Issue 4-5, 2008, Pages 123-151

  Sabbah, Michèle ^a   Emami, Shahin ^a   Redeuilh, Gérard ^a   Julien, Sylvia ^b   Prévost, Grégoire ^b   Zimber, Amazia ^a   Ouelaa, Radia ^a   Bracke, Marc ^c   De Wever, Olivier ^a,c   Gespach, Christian ^a  

^a INSERM   (France)

^b IPSEN   (France)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

AKT; GPCR; MicroRNAs; NF B; Notch; Receptor tyrosine kinases; Src; TGF ; WISP 2 and 3; Wnt PKC

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; AMG 479; AS 703026; B 9870; BEVACIZUMAB; BEZ 235; BIM 46174; BOSUTINIB; CEDIRANIB; CETUXIMAB; CP 751871; DASATINIB; ENZASTAURIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ERX 3722; EVEROLIMUS; GEFITINIB; GSK 690693; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; N (5 CHLORO 1,3 BENZODIOXOL 4 YL) 7 [2 (4 METHYL 1 PIPERAZINYL)ETHOXY] 5 (TETRAHYDRO 2H PYRAN 4 YLOXY) 4 QUINAZOLINAMINE; NK 4; NVP AEW 541; OT 304; PERIFOSINE; PKC 412A; PNU 74654; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RAPAMYCIN; SDX 101; SL 301; SMAD PROTEIN; TEMSIROLIMUS; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VITRONECTIN RECEPTOR; VQD 002; XL 765;

ARTICLE; CANCER RESISTANCE; CELL TRANSFORMATION; DRUG ACTIVITY; DRUG MECHANISM; EPITHELIUM CELL; EPITHELIUM TUMOR; GENE SILENCING; GENE TRANSFER; MESENCHYME CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MESODERM; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 53249130662     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2008.07.001     Document Type: Article

References (215)

1. Acevedo V.D., Gangula R.D., Freeman K.W., Li R., Zhang Y., Wang F., et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12 (2007) 559-571
2. Acloque H., Thiery J.-P., and Nieto M.A. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep. 9 (2008) 322-326
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3983-3988
4. Allen L.F., Sebolt-Leopold J.S., and Meyer M.B. CI-1040 (PD-184,352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30 (2003) 105-116
5. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., and Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10 (2008) 619-624
6. Alonso S.R., Tracey L., Ortiz P., Pérez-Gómez B., Palacios J., Pollán M., et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 67 (2007) 3450-3460
7. Andarawewa K.L., Erickson A.C., Chou W.S., Costes S.V., Gascard P., Mott J.D., Bissell M.J., and Barcellos-Hoff M.H. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res. 67 (2007) 8662-8670
8. André F., Janssens B., Bruyneel E., van Roy F., Gespach C., Mareel M., and Bracke M. α-catenin is required for IGF-I induced cellular migration but not invasion in human colonic cancer cells. Oncogene 23 (2004) 1177-1186
9. Atfi A., Djelloul S., Chastre E., Davis R., and Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J. Biol. Chem. 272 (1997) 1429-1432
10. Bachelder R.E., Yoon S.O., Franci C., de Herreros A.G., and Mercurio A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol. 168 (2005) 29-33
11. Bailey J.M., Singh P.K., and Hollingsworth M.A. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, notch, and bone morphogenic proteins. J. Cell Biochem. 102 (2007) 829-839
12. Bailey K.M., and Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. J. Biol. Chem. 283 (2008) 13714-13724
13. Barbier M., Attoub S., Calvez R., Laffargue M., Jarry A., Mareel M., Altruda F., Gespach C., Wu D., Lu B., Hirsch E., and Wymann M.P. Tumour biology. Weakening link to colorectal cancer?. Nature 413 (2001) 796
14. Barr S., Thomson S., Buck E., Russo S., Petti F., Sujka-Kwok I., et al. Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin. Exp. Metast. 25 (2008) 685-693
15. Bauer T.W., Somcio R.J., Fan F., Liu W., Johnson M., Lesslie D.P., Evans D.B., Gallick G.E., and Ellis L.M. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol. Cancer Ther. 5 (2006) 1676-1682
16. Bedogni B., Welford S.M., Cassarino D.S., Nickoloff B.J., Giaccia A.J., and Powell M.B. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8 (2005) 443-454
17. Behari J., Zeng G., Otruba W., Thompson M.D., Muller P., Micsenyi A., Sekhon S.S., Leoni L., and Monga S.P. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells. J. Hepatol. 46 (2007) 849-857
18. Bellacosa A., de Feo D., Godwin A.K., Bell D.W., Cheng J.Q., Altomare D.A., et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer 64 (1995) 280-285
19. Blanco M.J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., and Nieto M.A. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21 (2002) 3241-3246
20. Blaustein M., Pelisch F., Coso O.A., Bissell M.J., Kornblihtt A.R., and Srebrow A. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J. Biol. Chem. 279 (2004) 21029-21037
21. Blaustein M., Pelisch F., Tanos T., et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 12 (2005) 1037-1044
22. Blaustein M., Pelisch F., and Srebrow A. Signals, pathways and splicing regulation. Int. J. Biochem. Cell. Biol. 39 (2007) 2031-2048
23. Boccaccio C., and Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer 8 (2006) 637-645
24. Bos R., Zhong H., Hanrahan C.F., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93 (2001) 1175-1177
25. Boutet A., De Frutos C.A., Maxwell P.H., Mayol M.J., Romero J., and Nieto M.A. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J. 25 (2006) 5603-5613
26. Broxterman H.J., and Georgopapadakou N.H. Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma. Drug Resist. Update 10 (2007) 182-193
27. Burgermeister, E., Liscovitch, M., Röcken, C., Schmid, R.M., Ebert, M.P., in press. Caveats of caveolin-1 in cancer progression. Cancer Lett.
28. Cao Y., and Karin M. NF-kappaB in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8 (2003) 215-223
29. Carver L.A., and Schnitzer J.E. Caveolae: mining little caves for new cancer targets. Nat. Rev. Cancer 3 (2003) 571-581
30. Chan D.C., Gera L., Stewart J.M., et al. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin. Cancer Res. 8 (2002) 1280-1287
31. Chastre E., Empereur S., Di Gioia Y., El Mahdani N., Mareel M., Vleminckx K., Van Roy F., Bex V., Emami S., Spandidos D., and Gespach C. Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes. Gastroenterology 105 (1993) 1776-1789
32. Chen X., Halberg R.B., Burch R.P., and Dove W.F. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J. Mol. Histol. 39 (2008) 283-294
33. Cheng G.Z., Chan J., Wang Q., Zhang W., Sun C.D., and Wang L.H. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 67 (2007) 1979-1987
34. Cheng G.Z., Zhang W., and Wang L.H. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res. 68 (2008) 957-960 (Review)
35. Chua H.L., Bhat-Nakshatri P., Clare S.E., Morimiya A., Badve S., and Nakshatri H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26 (2007) 711-724
36. Cicchini C., Laudadio I., Citarella F., et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp. Cell Res. 314 (2008) 143-152
37. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
38. Cogswell P.C., Guttridge D.C., Funkhouser W.K., and Baldwin A.S. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19 (2000) 1123-1131
39. Criswell T.L., and Arteaga C.L. Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility. J. Biol. Chem. 282 (2007) 32491-32500
40. Damonte P., Gregg J.P., Borowsky A.D., Keister B.A., and Cardiff R.D. EMT tumorigenesis in the mouse mammary gland. Lab. Invest. 87 (2007) 1218-1226
41. Debidda M., Williams D.A., and Zheng Y. Rac1 GTPase regulates cell genomic stability and senescence. J. Biol. Chem. 281 (2006) 38519-38528
42. Delage S., Chastre E., Empereur S., Wicek D., Veissiére D., Capeau J., Gespach C., and Cherqui G. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res. 53 (1993) 2762-2770
43. Delbaldo C., Raymond E., Vera K., Hammershaimb L., Kaucic K., Lozahic S., Marty M., and Faivre S. Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. Invest. New Drugs 26 (2008) 35-43
44. De Wever O., Nguyen Q.-D., Van Hoorde L., Brake M., Bruyneel E., Gespach C., and Mareel M. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18 (2004) 1016-1028
45. Dewhirst M.W., Cao Y., and Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8 (2008) 425-437
46. Dhasarathy A., Kajita M., and Wade P.A. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol. Endocrinol. 21 (2007) 2907-2918
47. Dissanayake S.K., Wade M., Johnson C.E., et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282 (2007) 17259-17271
48. Dudek A.Z., Zwolak P., Jasinski P., Terai K., Gallus N.J., Ericson M.E., and Farassati F. Protein kinase C-beta inhibitor enzastaurin (LY317615 HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis. Invest. New Drugs 26 (2008) 13-24
49. Eckstein N., Servan K., Girard L., Cai D., von Jonquieres G., Jaehde U., et al. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283 (2008) 739-750
50. El Fitori J., Su Y., Büchler P., et al. PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer. Cancer 110 (2007) 1457-1468
51. Elias M.C., Tozer K.R., Silber J.R., et al. TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7 (2005) 824-837
52. Emami S., Mir L., Gespach C., and Rosselin G. Transfection of fetal rat intestinal epithelial cells by viral oncogenes: establishment and characterization of the E1A-immortalized SLC-11 cell line. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3194-3198
53. Empereur S., Djelloul S., Di Gioia Y., et al. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the Src or polyoma middle T oncogenes. Cooperation between Src and HGF/Met in invasion. Br. J. Cancer 75 (1997) 241-250
54. Escrivà M., Peiró S., Herranz N., et al. Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol. Cell. Biol. 28 (2008) 1528-1540
55. Faivre S., Kroemer G., and Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 5 (2006) 671-688
56. Felding-Habermann B., O'Toole T.E., Smith J.W., Fransvea E., Ruggeri Z.M., Ginsberg M.H., et al. Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1853-1858
57. Fiegen D., Haeusler L.C., Blumenstein L., Herbrand U., Dvorsky R., Vetter I.R., and Ahmadian M.R. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem. 279 (2004) 4739-4743
58. Fischer O.M., Giordano S., Comoglio P.M., and Ullrich A. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J. Biol. Chem. 279 (2004) 28970-28978
59. Fojo T. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug Resist. Update 10 (2007) 59-67
60. Frederick B.A., Helfrich B.A., Coldren C.D., Zheng D., Chan D., Bunn P.A., and Raben D. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol. Cancer Ther. 6 (2007) 1683-1691
61. Freeman K.W., Welm B.E., Gangula R.D., Rosen J.M., Ittmann M., Greenberg N.M., and Spencer D.M. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 63 (2003) 8256-8263
62. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134 (2008) 1655-1669
63. Fritah A., Saucier C., De Wever O., Bracke M., Bièche I., Lidereau R., et al. Role of WISP-2/CCN5 in the maintenance of a differentiated and non-invasive phenotype in human breast cancer cells. Mol. Cell. Biol. 28 (2008) 1114-1123
64. Fuchs B.C., Fujii T., Dorfman J.D., Goodwin J.M., Zhu A.X., Lanuti M., and Tanabe K.K. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res. 68 (2008) 2391-2399
65. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., and Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113 (2003) 207-219
66. Garber K. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J. Natl. Cancer Inst. 100 (2008) 232-233 239
67. Gavert N., and Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med. 14 (2008) 199-209
68. Graham T.R., Zhau H.E., Odero-Marah V.A., et al. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68 (2008) 2479-2488
69. Gravdal K., Halvorsen O.J., Haukaas S.A., and Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 13 (2007) 7003-7011
70. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., and Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10 (2008) 593-601
71. Grijelmo C., Rodrigue C., Svrcek M., Bruyneel E., Hendrix A., De Wever O., and Gespach C. Proinvasive activity of BMP-7 through SMAD4/Src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell. Sign. 19 (2007) 1722-1732
72. Grille S.J., Bellacosa A., Upson J., Klein-Szanto A.J., van Roy F., Lee-Kwon W., et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63 (2003) 2172-2178
73. Grotegut S., von Schweinitz D., Christofori G., and Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 25 (2006) 3534-3545
74. Hamada S., Satoh K., Hirota M., Kimura K., Kanno A., Masamune A., and Shimosegawa T. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J. Cell Physiol. 213 (2007) 768-774
75. Hähnel P.S., Thaler S., Antunes E., Huber C., Theobald M., and Schuler M. Targeting AKT signaling sensitizes cancer to cellular immunotherapy. Cancer Res. 68 (2008) 3899-3906
76. Hellman N.E., Spector J., Robinson J., Zuo X., Saunier S., Antignac C., Tobias J.W., and Lipschutz J.H. Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J. Biol. Chem. 283 (2008) 4272-4282
77. Hertel K.J. Combinatorial control of exon recognition. J. Biol. Chem. 283 (2008) 1211-1215
78. Higgins D.F., Kimura K., Bernhardt W.M., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117 (2007) 3810-3820
79. Horikawa T., Yang J., Kondo S., Yoshizaki T., Joab I., Furukawa M., and Pagano J.S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67 (2007) 1970-1978
80. Hosseini M., Rose A.Y., Song K., Bohan C., Alexander J.P., Kelley M.J., and Acott T.S. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1469-1476
81. Hotz B., Arndt M., Dullat S., Bhargava S., Buhr H.J., and Hotz H.G. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin. Cancer Res. 13 (2007) 4769-4776
82. House A.E., and Lynch K.W. Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283 (2008) 1217-1221
83. Huang Y., Fernandez S.V., Goodwin S., Russo P.A., Russo I.H., Sutter T.R., and Russo J. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res. 67 (2007) 11147-11157
84. Huang W., Zhang Y., Varambally S., Chinnaiyan A.M., Banerjee M., Merajver S.D., and Kleer C.G. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am. J. Pathol. 172 (2008) 893-904
85. Huber M.A., Azoitei N., Baumann B., et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (2004) 569-581
86. Hurteau G.J., Carlson J.A., Spivack S.D., and Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 67 (2007) 7972-7976
87. Ignatoski K.M., Maehama T., Markwart S.M., Dixon J.E., Livant D.L., and Ethier S.P. ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br. J. Cancer 82 (2000) 666-674
88. Ito Y., Takeda T., Sakon M., Tsujimoto M., Higashiyama S., Noda K., et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br. J. Cancer 84 (2001) 1377-1383
89. Jin J., and Woodgett J.R. Chronic activation of protein kinase Bbeta/Akt2 leads to multinucleation and cell fusion in human epithelial kidney cells: events associated with tumorigenesis. Oncogene 24 (2005) 5459-5470
90. Jinde K., Nikolic-Paterson D.J., Huang X.R., Sakai H., Kurokawa K., Atkins R.C., and Lan H.Y. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am. J. Kidney Dis. 38 (2001) 761-769
91. Jordà M., Olmeda D., Vinyals A., Valero E., Cubillo E., Llorens A., Cano A., and Fabra A. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118 (2005) 3371-3385
92. Jordan P., Brazao R., Boavida M.G., Gespach C., and Chastre E. Cloning of a novel human Rac1b splice variant with increased expression in human colorectal cancers. Oncogene 18 (1999) 6835-6939
93. Julien S., Puig I., Caretti E., Bonaventure J., Nelles L., van Roy F., et al. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26 (2007) 7445-7456
94. Kalaitzidis D., and Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 16 (2005) 46-52
95. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112 (2003) 1776-1784
96. Kefas B., Godlewski J., Comeau L., et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68 (2008) 3566-3572
97. Kim H.J., Litzenburger B.C., Cui X., et al. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol. Cell. Biol. 27 (2007) 3165-3175
98. Kim K., Lu Z., and Hay E.D. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26 (2002) 463-476
99. Kim S., Lee Y., Seo J.E., Cho K.H., and Chung J.H. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell Signal. 20 (2008) 1313-1319
100. Korpal M., Lee E.S., Hu G., and Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. (2008) 14910-14914
101. Kotelevets L., Noë V., Bruyneel E., Myssiakine E., Chastre E., Mareel M., and Gespach C. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells Phosphatidylinositol-3′-kinase is a critical mediator of tumor invasion. J. Biol. Chem. 273 (1998) 14138-14145
102. Kotelevets L., van Hengel J., Bruyneel E., Mareel M., van Roy F., and Chastre E. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. J. Cell Biol. 155 (2001) 1129-1135
103. Kotelevets L., van Hengel J., Bruyneel E., Mareel M., van Roy F., and Chastre E. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J. 19 (2005) 115-117
104. Krueckl S.L., Sikes R.A., Edlund N.M., Bell R.H., Hurtado-Coll A., Fazli L., Gleave M.E., and Cox M.E. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res. 64 (2004) 8620-8629
105. Kumar M.S., Lu J., Mercer K.L., Golub T.R., and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39 (2007) 673-677
106. Kwok W.K., Ling M.T., Lee T.W., et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65 (2005) 5153-5162
107. Kwok W.K., Ling M.T., Yuen H.F., Wong Y.C., and Wang X. Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells. Carcinogenesis 28 (2007) 2467-2475
108. Lacey J.V., Mink P.J., Lubin J.H., Sherman M.E., Troisi R., Hartge P., Schatzkin A., and Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288 (2002) 334-341
109. Lamouille S., and Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol. 178 (2007) 437-451
110. Laurent E., McCoy J.W., Macina R.A., Liu W., Cheng G., Robine S., Papkoff J., and Lambeth J.D. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int. J. Cancer 123 (2008) 100-107
111. Lee T.K., Poon R.T., Yuen A.P., et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 12 (2006) 5369-5376
112. Lee S.A., Lee S.Y., Cho I.H., et al. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J. Clin. Invest. 118 (2008) 1354-1366
113. Le Floch N., Rivat C., De Wever O., Bruyneel E., Mareel M., Dale T., and Gespach C. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3-beta and c-jun/AP-1 signaling. FASEB J. 19 (2005) 144-146
114. Le Floch N., Forgez P., Souaze F., et al. Wnt signaling in normal development and cancer progression. In: Dave Caplin E. (Ed). Trends in Cellular Signaling (2006), Nova Science Publishers, New York 143-227
115. Leong K.G., Niessen K., Kulic I., Raouf A., Eaves C., Pollet I., and Karsan A. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med. 204 (2007) 2935-2948
116. Leslie N.R., Yang X., Downes C.P., and Weijer C.J. PtdIns(3,4 5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr. Biol. 17 (2007) 115-125
117. Lester R.D., Jo M., Montel V., Takimoto S., and Gonias S.L. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 178 (2007) 425-436
118. Liu P., Rudick M., and Anderson R.G. Multiple functions of caveolin-1. J. Biol. Chem. 277 (2002) 41295-41298
119. Lo H.W., Hsu S.C., Xia W., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67 (2007) 9066-9076
120. LoPiccolo J., Blumenthal G.M., Bernstein W.B., and Dennis P.A. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist. Update 11 (2008) 32-50
121. Lorch J.H., Klessner J., Park J.K., Getsios S., Wu Y.L., Stack M.S., and Green K.J. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J. Biol. Chem. 279 (2004) 37191-37200
122. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
123. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
124. Mabuchi S., Altomare D.A., Connolly D.C., Klein-Szanto A., Litwin S., Hoelzle M.K., et al. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res. 67 (2007) 2408-2413
125. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., Kedes L., Doglioni C., Beach D.H., and Hannon G.J. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13 (1999) 2207-2217
126. Mandal M., Myers J.N., Lippman S.M., et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112 (2008) 2088-2100
127. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
128. Matos P., and Jordan P.O. Expression of Rac1b stimulates NF-kappaB-mediated cell survival and G1/S progression. Exp. Cell Res. 305 (2005) 292-299
129. Mazelin L., Bernet A., Bonod-Bidaud C., Pays L., Arnaud S., Gespach C., et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431 (2004) 80-84
130. Meigs T.E., Fedor-Chaiken M., Kaplan D.D., Brackenbury R., and Casey P.J. Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin. J. Biol. Chem. 277 (2002) 24594-24600
131. Moody S.E., Perez D., Pan T.C., et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 8 (2005) 197-209
132. Moreno-Bueno G., Cubillo E., Sarrió D., Peinado H., Rodríguez-Pinilla S.M., Villa S., et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 66 (2006) 9543-9556
133. Moser C., Schachtschneider P., Lang S.A., Gaumann A., Mori A., Zimmermann J., et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Eur. J. Cancer. 44 (2008) 1577-1586
134. Mueller K.L., Hunter L.A., Ethier S.P., and Boerner J.L. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 68 (2008) 3314-3322
135. Mulgrew K., Kineer K., Yao X.T., et al. Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody. Abegrin. Mol. Cancer Ther. 5 (2006) 3122-3129
136. Muschel R.J., and Gal A. Tetraspanin in oncogenic epithelial-mesenchymal transition. J. Clin. Invest. 118 (2008) 1347-1350
137. Nguyen Q.-D., Faivre S., Bruyneel E., Rivat C., Seto M., Endo T., Mareel M., Emami S., and Gespach C. RhoA- and RhoD-dependent regulatory switch of Gα-subunits signaling by PAR-1 receptors in cellular invasion. FASEB J. 16 (2002) 565-576
138. Nguyen Q.-D., De Wever O., Bruyneel E., Hendrix A., Xie W.Z., Lombet A., et al. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-ROK axis and tumor microenvironment. Oncogene 24 (2005) 8240-8251
139. Nguyen Q.-D., Rodrigues S., Rodrigue C., Rivat C., Grijelmo C., Bruyneel E., Emami S., Attoub S., and Gespach C. Inhibition of VEGF-165 and Semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol. Cancer Ther. 5 (2006) 2070-2071
140. Nishi E., and Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. Growth Factors 22 (2004) 253-260
141. Noë, V., Chastre, E., Bruyneeel, E., Gespach, C., Mareel M., 1999. Extracellular regulation of cancer invasion: the E-cadherin/catenin and other pathways. In: Lackie, J.M., Dunn, G.A., Jones, G.E. (Eds.), Cell Behaviour: Control and Mechanism of Motility. Biochemical Society Symp. Abercrombie Memorial, Symposium N°65, Portland Press, Oxford, UK, pp. 43-62.
142. Ogura Y., Mizumoto K., Nagai E., et al. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival. Cancer Gene Ther. 13 (2006) 520-529
143. Ostman A., and Heldin C.H. PDGF receptors as targets in tumor treatment. Adv. Cancer Res. 97 (2007) 247-274
144. Overholtzer M., Mailleux A.A., Mouneimne G., Normand G., Schnitt S.J., King R.W., Cibas E.S., and Brugge J.S. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131 (2007) 966-979
145. Ozen M., Giri D., Ropiquet F., Mansukhani A., and Ittmann M. Role of fibroblast growth factor receptor signaling in prostate cancer cell survival. J. Natl. Cancer Inst. 93 (2001) 1783-1790
146. Park, S.H., Cheung, L.W., Wong, A.S., Leung, P.C., in press. Estrogen regulates Snail and Slug in the downregulation of E-Cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol. Endocrinol.
147. Park S.M., Gaur A.B., Lengyel E., and Peter M.E. The miR-200 family
148. Pawelek J.M., and Chakraborty A.K. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat. Rev. Cancer 8 (2008) 377-386
149. Peinado H., Olmeda D., and Cano A. Snail Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7 (2007) 415-428
150. Pelisch F., Blaustein M., Kornblihtt A.R., and Srebrow A. Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J. Biol. Chem. 280 (2005) 25461-25469
151. Porte H., Chastre E., Prévot S., Nordlinger B., Empereur S., Basset P., Chambon P., and Gespach C. Neoplastic progression of human colorectal cancer is associated with overexpression of the ST3 and BM-40/SPARC genes. Int. J. Cancer 64 (1995) 1-6
152. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
153. Prévost G.P., Lonchampt M.O., Holbeck S., Attoub S., Zaharevitz D., Alley M., et al. Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Gα/Gβγ complex. Cancer Res. 66 (2006) 9227-9234
154. Przybylo J.A., and Radisky D.C. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace. Int. J. Biochem. Cell Biol. 39 (2007) 1082-1088
155. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
156. Radisky D.C., and Bissell M.J. NF-kappaB links oestrogen receptor signalling and EMT. Nat. Cell Biol. 9 (2007) 361-363
157. Rivat C., LeFloch N., Sabbah M., Redeuilh G., Bruyneel E., Mareel M., Matrisian L., Crowford H., Gespach C., and Attoub S. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in the activation of the matrilysin promoter by the Src oncogene. Consequences on tumor cell invasion. FASEB J. 17 (2003) 1721-1723
158. Rivat C., Rodrigues S., Bruyneel E., Piétu G., Robert A., Redeuilh G., Brake M., Gespach C., and Attoub S. Implication of STAT3 signaling in human colonic cancer cells during Intestinal trefoil factor (TFF3) and VEGF-mediated cellular invasion and tumor growth. Cancer Res. 65 (2005) 195-202
159. Rodrigues S., Nguyen Q.D., Faivre S., Bruyneel E., Thim L., Westley B., et al. Activation of cellular invasion by trefoil peptides and Src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. FASEB J. 15 (2001) 1517-1528
160. Rodrigues S., Attoub S., Nguyen Q.-D., Bruyneel E., Rodrigue C., Westley B., et al. Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene 222 (2003) 4488-4497
161. Rodrigues S., Bruyneel E., Rodrigue C., Emami S., and Gespach C. COX-2 et carcinogenèse. Bull. Cancer 91 (2004) S59-S76
162. Rodrigues S., De Wever O., Bruyneel E., Rooney R.J., and Gespach C. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26 (2007) 5615-5625
163. Rosanò L., Spinella F., Di Castro V., Nicotra M.R., Dedhar S., de Herreros A.G., Natali P.G., and Bagnato A. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res. 65 (2005) 11649-11657
164. Rosenfeld N., Aharonov R., Meiri E., Rosenwald S., Spector Y., Zepeniuk M., et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 26 (2008) 462-469
165. Rozengurt E. Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol. Metab. 13 (2002) 128-134
166. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., and Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 6392-6397
167. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., and Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68 (2008) 989-997
168. Satoh K., Hamada S., Kimura K., Kanno A., Hirota M., Umino J., et al. Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am. J. Pathol. 172 (2008) 926-939
169. Saumet, A., Vetter, G., Cougot, N., Bouttier, M., Rage, F., Arar, K., Lecellier C.H., in press. MiRNAs associated therapies. In: Current Research and Perspectives in MicroRNAs. Springer Biomedical Sciences.
170. Schmierer B., and Hill C.S. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8 (2007) 970-982
171. Shintani Y., Fukumoto Y., Chaika N., Svoboda R., Wheelock M.J., and Johnson K.R. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J. Cell Biol. 180 (2008) 1277-1289
172. Shrader M., Pino M.S., Brown G., et al. Molecular correlates of gefitinib responsiveness in human bladder cancer cells. Mol. Cancer Ther. 6 (2007) 277-285
173. Si Z., and Hersey P. Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells. Pathology 26 (1994) 6-15
174. Singh A., Karnoub A.E., Palmby T.R., et al. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23 (2004) 9369-9380
175. Skorski T. Oncogenic tyrosine kinases and the DNA-damage response. Nat. Rev. Cancer 2 (2002) 351-360 (Review)
176. Sok J.C., Coppelli F.M., Thomas S.M., Lango M.N., Xi S., Hunt J.L., et al. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin. Cancer Res. 12 (2006) 5064-5073
177. Spaderna S., Schmalhofer O., Hlubek F., Berx G., Eger A., Merkel S., Jung A., Kirchner T., and Brabletz T. A transient EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131 (2006) 830-840
178. Spaderna S., Schmalhofer O., Wahlbuhl M., Dimmler A., Bauer K., Sultan A., et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 68 (2008) 537-544
179. Stemmer, V., de Craene, B., Berx, G., Behrens, J., in press. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene.
180. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
181. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516
182. Suganuma K., Kubota T., Saikawa Y., et al. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray. Cancer Sci. 94 (2003) 355-359
183. Tanaka A., Muto S., Konno M., Itai A., and Matsuda H. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition. Cancer Res. 66 (2006) 419-426
184. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
185. Thiery J.-P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 7 (2006) 131-142
186. Thomas S.M., Bhola N.E., Zhang Q., Contrucci S.C., Wentzel A.L., Freilino M.L., et al. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res. 66 (2006) 11831-11839
187. Thomson S., Buck E., Petti F., Griffin G., Brown E., Ramnarine N., Iwata K.K., Gibson N., and Haley J.D. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 65 (2005) 9455-9462
188. Tokatli F., Altaner S., Uzal C., Ture M., Kocak Z., Uygun K., and Bilgi S. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients. Exp. Oncol. 27 (2005) 145-149
189. Trimboli A.J., Fukino K., de Bruin A., Wei G., Shen L., Tanner S.M., et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68 (2008) 937-945
190. Van Slambrouck S., Grijelmo C., De Wever O., Emami S., Steelant F.A., and Gespach C. Activation of the FAK-Src scaffolds and p130Cas-JNK signalling cascades by α1-integrins during colon cancer cell invasion. Int. J. Oncol. 31 (2007) 1501-1508
191. Vider B., Zimber A., Chastre E., et al. Evidence for the involvement of the Wnt-2 gene in human colorectal cancer. Oncogene 12 (1996) 153-158
192. Wanami L.S., Chen H.Y., Peiró S., García de Herreros A., and Bachelder R.E. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp. Cell Res. 314 (2008) 2448-2453
193. Wang F., Sloss C., Zhang X., Lee S.W., and Cusack J.C. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. Cancer Res. 67 (2007) 8486-8493
194. Wang F., Liu R., Lee S.W., Sloss C.M., Couget J., and Cusack J.C. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance. Oncogene 26 (2007) 2006-2016
195. Wang H., Quah S.Y., Dong J.M., Manser E., Tang J.P., and Zeng Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res. 67 (2007) 2922-2926
196. Wang H., Leav I., Ibaragi S., Wegner M., Hu G.F., Lu M.L., Balk S.P., and Yuan X. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 68 (2008) 1625-1630
197. Wang X., Ling M.T., Guan X.Y., Tsao S.W., Cheung H.W., Lee D.T., and Wong Y.C. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23 (2004) 474-482
198. Wang X., Belguise K., Kersual N., et al. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9 (2007) 470-478
199. Witta S.E., Gemmill R.M., Hirsch F.R., et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 66 (2006) 944-950
200. Wodarz A., and Näthke I. Cell polarity in development and cancer. Nat. Cell Biol. 9 (2007) 1016-1024 (Review)
201. Wong R.P., Ng P., Dedhar S., and Li G. The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol. Cancer Ther. 6 (2007) 1692-1700
202. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354 (2006) 270-282
203. Yang A.D., Fan F., Camp E.R., van Buren G., Liu W., Somcio R., et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 12 (2006) 4147-4153
204. Yang A.D., Camp E.R., Fan F., Shen L., Gray M.J., Liu W., et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66 (2006) 46-51
205. Yang M.H., Wu M.Z., Chiou S.H., Chen P.M., Chang S.Y., Liu C.J., Teng S.C., and Wu K.J. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 10 (2008) 295-305
206. Yauch R.L., Januario T., Eberhard D.A., et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res. 11 (2005) 8686-8698
207. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., and Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67 (2007) 10123-10128
208. Zeisberg E.M., Yang C., Martino M., Duncan M.B., Rieder F., Tanjore H., and Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282 (2007) 23337-23347
209. Zhang A., Jia Z., Guo X., and Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am. J. Physiol. Renal. Physiol. 293 (2007) F723-F731
210. Zhang X., Ling M.T., Wang Q., et al. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J. Biol. Chem. 282 (2007) 33284-33294
211. Zhang X., Wang Q., Ling M.T., Wong Y.C., Leung S.C., and Wang X. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int. J. Cancer. 120 (2007) 1891-1898
212. Zhang X., Zhu J., Yang G.Y., et al. Dishevelled promotes axon differentiation by regulating atypical protein kinase C. Nat. Cell Biol. 9 (2007) 743-754
213. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., and Hung M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6 (2004) 931-940
214. Zhuo W.L., Wang Y., Zhuo X.L., Zhang Y.S., and Chen Z.T. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. Biochem. Biophys. Res. Commun. 369 (2008) 1098-1102
215. Zhuo, W.L., Wang, Y., Zhuo, X., Zhang, Y., Ao, X., Chen, Z., in press. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. Lung Cancer.